BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Welichem Biotech Inc. (WBI.V) Announces Appointment of President & CEO


6/30/2008 7:08:58 AM

BURNABY, BC, June 27 /CNW/ - Welichem Biotech Inc. (the "Company") (TSX-V: WBI - News) today announces the appointment of Dr. Genhui Chen as President & CEO of the Company, effective immediately. A long time director and one of the founders of the Company, he will guide Welichem through the next crucial stage of development as it realizes the potential value of its drug candidates in clinical trials.

Dr. John Webster, Interim Chairman of the Company, stated that "He was very pleased that Dr. Chen had agreed to take up the key leadership role at Welichem at this time. He has a deep understanding of both the business and scientific components of the Company and related international experience in the biotech industry. His commitment and insight will be invaluable."

York Yingping Guo resigned as President & CEO for personal and family reasons. Dr. Webster opined that "Welichem Biotech has been very fortunate to have had York as its President and CEO. The Company has achieved significant milestones during his tenure and I am very grateful for the great contribution he has made to the Company."

About Welichem Biotech Inc.

Welichem Biotech Inc. is a publicly-traded biotechnology company developing therapeutic drugs in the fields of autoimmune and inflammatory diseases and cancer.

ON BEHALF OF THE BOARD John M. Webster Interim Chairman of Board of Directors

For further information

John M. Webster, Tel.: (604) 432-1703, Email: info@welichem.com Yan Chen, Business Development Manager, Tel.: (604) 432-1703, Email: investors@welichem.com

Source: Welichem Biotech Inc.

Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES